Improving the diagnostic yield from staging laparoscopy for periampullary malignancies: The value of preoperative inflammatory markers and radiological tumor size

Pancreas

Volumn 41, Issue 2, 2012, Pages 233-237

  Garcea, Giuseppe ^a   Cairns, Vaux ^a   Berry, David P ^a   Neal, Christopher P ^a   Metcalfe, Matthew S ^a   Dennison, Ashley R ^a  

^a UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

Author keywords

computed tomography; laparoscopy; NLR; periampullary cancer; PLR; staging

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; AMPULLARY ADENOCARCINOMA; ARTICLE; BILE DUCT CARCINOMA; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DUODENUM CANCER; HEAD OF PANCREAS DUCTAL ADENOCARCINOMA; HUMAN; HUMAN TISSUE; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; LAPAROSCOPY; LYMPHOCYTE; MAJOR CLINICAL STUDY; MUCINOUS CYSTIC NEOPLASM; NEUTROPHIL; PANCREAS CANCER; PANCREAS DUCT; PERIAMPULLARY MALIGNANCY; PRIORITY JOURNAL; RADIOLOGY; SCORING SYSTEM; SEROLOGY; THROMBOCYTE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; C-REACTIVE PROTEIN; CARCINOMA, PANCREATIC DUCTAL; ENGLAND; FEMALE; HUMANS; INFLAMMATION MEDIATORS; LAPAROSCOPY; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PLATELET COUNT; PREDICTIVE VALUE OF TESTS; PROGNOSIS; ROC CURVE; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84857919372     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31822432ee     Document Type: Article

References (27)

1. Boyd WP, Nord HJ. Diagnostic laparoscopy. Endoscopy. 2000;32: 153-158. (Pubitemid 30088717)
2. Tilleman EH, Kuiken BW, Phoa SS, et al. Limitation of diagnostic laparoscopy for patients with a periampullary carcinoma. Eur J Sur Oncol. 2004;30:658-662. (Pubitemid 39060737)
3. Conlon KC, Dougherty F, Klimstra DS, et al. The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy. Ann Surg. 1996;223:134-140 (Pubitemid 26065205)
4. Jimanez RE, Warshaw AL, Rattner DW, et al. Impact of laparoscopic staging in the treatment of pancreatic cancer. Arch Surg. 2000;135: 409-414.
5. Vollmer CM, Drebin JA, Middleton WD, et al. Utility of staging laparoscopy in subsets of peripancreatic and biliary malignancies. Ann Surg. 2002;235:1-7. (Pubitemid 34062393)
6. Doran HE, Bosneet L, Connor S, et al. Laparoscopy and laparoscopic ultrasound in the evaluation of pancreatic and periampullary tumours. Dig Surg. 2004;21:305-313. (Pubitemid 39370396)
7. Nievenn va Dijkum EJ, Romjin MG, Terwee CB, et al. Laparoscopic staging and subsequent palliation in patients with peripancreatic carcinoma. Ann Surg. 2003;237:66-73. (Pubitemid 36622319)
8. Thomson BN, Parks RW, Redhead DN, et al. Refining the role of laparoscopy and laparoscopic ultrasound in the staging of presumed pancreatic head and ampullary tumours. Br J Cancer. 2006;94:213-217. (Pubitemid 43151538)
9. Stefandis D, Grove KD, Schewesinger WH, et al. The current role of staging laparoscopy for adenocarcinoma of the pancreas: a review. Ann Oncol. 2006;17:189-199. (Pubitemid 43160105)
10. Karachristos A, Carmeas N, Hoffman JP, et al. Ca19.9 levels predict results of staging laparoscopy in pancreatic cancer. J Gastrointest Surg. 2005;9:1286-1292. (Pubitemid 41751121)
11. Smith RA, Bosonnet L, Ghaneh P, et al. The platelet-lymphocyte ratio improves the predictive value of serum CA19-9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancer. Surgery. 2008;143:658-666.
12. Ong SL, Garcea G, Thomasset SC, et al. Surrogate markers of resectability in patients undergoing exploration of potentially resectable pancreatic adenocarcinoma. J Gastrointest Surg. 2008;12:1068-1073.
13. Glen P, Jamieson NB, McMillan DC, et al. Evaluation of an inflammation-based prognostic score in patients with inoperable pancreas cancer. Pancreatology. 2006;6:450-453. (Pubitemid 44624278)
14. Doucas H, Sutton CD, Zimmerman A, et al. Assessment of pancreatic malignancy with laparoscopy and intraoperative ultrasound. Surg Endosc. 2007;21:1147-1152. (Pubitemid 47024748)
15. Barabino M, Santambrogio R, Pisani Ceretti A, et al. Is there still a role for laparoscopy combined with laparoscopic ultrasonography in the staging of pancreatic cancer? Surg Endosc. 2011;25:160-165.
16. Nieveen va Dijukum EJ, de Wit LT, et al. The efficacy of laparoscopic staging in patients with upper gastrointestinal tumours. Cancer. 1997;79:1315-1319. (Pubitemid 27143237)
17. Shand AG, Grieve DC, Brush J, et al. Expandable metallic stents for palliation of malignant pyloric and duodenal obstruction. Br J Surg. 2002;89:349-350. (Pubitemid 34227036)
18. Scott EN, Garcea G, Doucas H, et al. Surgical bypass vs. endoscopic stenting for pancreatic ductal adenocarcinoma. HPB (Oxford). 2009;11:118-124.
19. Mann CD, Thomasset SC, Johnson NA, et al. Combined biliary and gastric bypass procedures as effective palliation for unresectable malignant disease. ANZ J Surg. 2009;79:471-512.
20. Garcea G, Dennison AR, Pattenden CJ, et al. Survival following curative resection for pancreatic ductal adenocarcinoma: a systematic review of the literature. JOP. 2008;9:99-132. (Pubitemid 351611725)
21. Morganti AG, Brizi MG, Macchia G, et al. The prognostic effect of clinical staging in pancreatic adenocarcinoma. Ann Surg Oncol. 2005;12:145-151. (Pubitemid 40486623)
22. Yoshida T, Matsumoto T, Morii Y, et al. Staging with helical computed tomography and laparoscopy in pancreatic head cancer. Hepatogastroenterol. 2002;49:1428-1431.
23. MüllerMW, Friess H, Köninger J, et al. Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas. Am J Surg. 2008;195:221-228.
24. Tingstedt B, Johansson P, Andersson B, et al. Predictive factors in pancreatic ductal adenocarcinoma: role of the inflammatory response. Scan J Gastroenterol. 2007;42:754-759. (Pubitemid 46763583)
25. Aliustaoglu M, Bilici A, Seker M, et al. The association of pre-treatment peripheral blood markers with survival in patients with pancreatic cancer. Hepatogastroenterol. 2010;57:640-645.
26. Bhatti I, Peacock O, Lloyd G, et al. Preoperative hematological markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio. Am J Surg. 2010;200:197-203.
27. van der Gaag NA, Rauws EA, van Eijck CH, et al. Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med. 2010;362:129-137.